Paragraph 7
United Kingdom
F1The entries or a succinct statement of the entries (if any) in the summary of the product characteristicsF2, or in any equivalent summary published by the holder of a temporary authorisation, relating to—
adverse reactions, precautions and relevant contra-indications;
dosage and method of use so far as relevant to the indications shown in the advertisement, and
where this is not obvious, method of administration so far as relevant to those indications.
Annotations
Textual amendments
- F1
Words in Sch. 30 para. 7 substituted (E.W.S.) (1.10.2014) by The Human Medicines (Amendment) (No. 2) Regulations 2014 (S.I. 2014/1878), regs. 1, 29 and words in Sch. 30 para. 7 substituted (N.I.) (1.10.2014) by The Human Medicines (Amendment) (No. 2) Regulations 2014 (S.R. 2014/324), regs. 1(1), 29
- F2
Words in Sch. 30 para. 7 inserted (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.I. 2020/1125), regs. 1(2), 33(4) and words in Sch. 30 para. 7 inserted (N.I.) (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.R. 2020/349), regs. 1(2), 33(4)